DR SHAH HOMEOPATHIC CLINIC LTD
Opportunity 70/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (69/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · FRS 105 (micro)Key financials
1 year extracted from filed iXBRL accountsFinancials
Extracted from Companies House accounts · FRS 105 (micro)| Metric | 2025-03-31 |
|---|---|
| Total assets | £2.2k |
| Current assets | £1.5k |
| Net assets | £1.9k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 accounts
Corporate timeline (4 events)Click to expand
- 2025-12-05📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-03-05🏢Company incorporatedAs DR SHAH HOMEOPATHIC CLINIC LTD
- 2024-03-05➕HASSAN, Shah, Dr appointeddirector
- 2024-03-05📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Young company: Only 2.1 years old — management layer unlikely to be developed.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Shah Hassan Individual · Pakistani · DOB 03/1988 · age 38 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 05/03/2024 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · DD postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ANGUS AND MEARNS RESOURCES LTD→ SC825444 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ANTRIG LIMITED→ SC552344 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
| BESTYOU THERAPIES ORMENO LIMITED→ SC650003 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| CARNOUSTIE, BARRY & PANBRIDE SICK NURSING ASSOCIATION→ SC169926 · est 1996 · no financials extracted | — | — | — | — | 29y | — | — |
| CASTLE LODGE (INVERBERVIE) LIMITED→ SC768857 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| CLEMENCE HARDANGE LTD→ SC597979 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| COULD CARE LTD→ SC848473 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| DOCTORS INC LTD→ SC816814 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| DP-PT LTD→ SC852250 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| DUNCARE LIMITED→ SC143116 · est 1993 · no financials extracted | — | — | — | — | 33y | — | — |
| DUNDEE INDEPENDENT ADVOCACY SUPPORT→ SC419193 · est 2012 · no financials extracted | — | — | — | — | 14y | — | — |
| DUNDEE LIFESTYLE TRANSFORMATION LIMITED→ SC568333 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.